Search
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 6 of 6 items.
… professionals at the identified Points of Use (POUs). Pfizer is distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination …
AlertHealth professional risk communication | 2021-03-08
… professionals at the identified Points of Use (POUs). Pfizer is initially distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination …
AlertHealth professional risk communication | 2020-12-12
… Media enquiries Public enquiries Summary Product: Pfizer-BioNTech COVID-19 vaccine Issue: Two individuals in the U.K. reported severe allergic reactions to Pfizer BioNTech’s COVID-19 vaccine on December 8, 2020. As …
AlertPublic advisory | 2020-12-12
… professionals at the identified Points of Use (POUs). Pfizer is distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination …
AlertHealth professional risk communication | 2021-02-09
… number: RA-75959 Last updated: 2021-06-30 Summary Product: Pfizer-BioNTech and Moderna COVID-19 vaccines Issue: Health Canada has updated the product monographs (labels) for the Pfizer-BioNTech and Moderna COVID-19 vaccines to describe …
AlertPublic advisory | 2021-06-30
… number: RA-76203 Last updated: 2021-08-06 Summary Product: Pfizer-BioNTech COVID-19 vaccine Issue: Health Canada has updated the product information for the Pfizer-BioNTech COVID-19 vaccine to describe very rare …
AlertPublic advisory | 2021-08-06